BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34515250)

  • 1. Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
    Shao G; Xu C; Liu J; Li X; Li L; Li X; Zhang X; Fan Y; Zhou L
    Urol Int; 2022; 106(2):199-208. PubMed ID: 34515250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
    Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY
    Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
    Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
    Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urachal carcinoma: Impact of recurrence pattern and lymphadenectomy on long-term outcomes.
    Duan F; Zhai W; Zhang B; Guo S
    Cancer Med; 2020 Jun; 9(12):4166-4174. PubMed ID: 32329250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant urachal neoplasms: A population-based study and systematic review of literature.
    Mylonas KS; O Malley P; Ziogas IA; El-Kabab L; Nasioudis D
    Urol Oncol; 2017 Jan; 35(1):33.e11-33.e19. PubMed ID: 27592530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoma of urachus: report of 15 cases and review of literature--is total cystectomy the treatment of choice for urachal carcinoma?].
    Asano K; Miki J; Yamada H; Maeda S; Abe K; Furuta A; Suzuki M; Onishi T; Kido A; Ueda M; Kawakami M; Onodera S; Oishi Y
    Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):487-94. PubMed ID: 12795163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.
    Ashley RA; Inman BA; Sebo TJ; Leibovich BC; Blute ML; Kwon ED; Zincke H
    Cancer; 2006 Aug; 107(4):712-20. PubMed ID: 16826585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
    Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the survival of bladder carcinoma patients treated with radical cystectomy.
    Cheng L; Weaver AL; Leibovich BC; Ramnani DM; Neumann RM; Scherer BG; Nehra A; Zincke H; Bostwick DG
    Cancer; 2000 May; 88(10):2326-32. PubMed ID: 10820355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urachal mass in adults: clinical analysis of 33 cases].
    Tian J; Ma JH; Li CL; Xiao ZD
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):820-2. PubMed ID: 18756985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urachal carcinoma: experience of a clinical center within 30 years].
    Shao GJ; Cai L; Li XS; Song G; Li XY; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):774-8. PubMed ID: 24136277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options and prognostic risk factors for urachal carcinoma: A multicetnter retrospective study.
    Ke C; Xu L; Wang M; Wang Y; Zhou Q; Chen J; Wang Z; Wang S; Hu Z; Yang C
    Urol Oncol; 2023 Jan; 41(1):50.e1-50.e9. PubMed ID: 36283930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for urachal cancer: a bayesian model-averaging approach.
    Kim IK; Lee JY; Kwon JK; Park JJ; Cho KS; Ham WS; Hong SJ; Yang SC; Choi YD
    Korean J Urol; 2014 Sep; 55(9):574-80. PubMed ID: 25237458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of 14 cases of urachal carcinoma].
    Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL
    Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
    Molina JR; Quevedo JF; Furth AF; Richardson RL; Zincke H; Burch PA
    Cancer; 2007 Dec; 110(11):2434-40. PubMed ID: 17932892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urachal carcinoma: contemporary surgical outcomes.
    Herr HW; Bochner BH; Sharp D; Dalbagni G; Reuter VE
    J Urol; 2007 Jul; 178(1):74-8; discussion 78. PubMed ID: 17499279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis.
    Niedworok C; Panitz M; Szarvas T; Reis H; Reis AC; Szendröi A; Nyirády P; Szasz AM; Módos O; Rübben H; Vom Dorp F
    J Urol; 2016 Jun; 195(6):1690-6. PubMed ID: 26678957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment methods as a prognostic factor in eight patients with urachal carcinoma].
    Yamada T; Fukui I; Sekine H; Kihara K; Oshima H
    Hinyokika Kiyo; 1991 Feb; 37(2):113-6. PubMed ID: 2048489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.